Trials / Unknown
UnknownNCT04661709
Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
Efficacy and Safety of Chinese Herbal Medicine Wen Xin Granules for the Treatment of Unstable Angina Pectoris With Yang Deficiency and Blood Stasis Syndrome: Study Protocol for a Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 502 (estimated)
- Sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 35 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a double-blind, randomized placebo-controlled trial which aims to evaluate the efficacy and safety of Wen Xin granule in patients with unstable angina pectoris.
Detailed description
Coronary heart disease has remained the leading cause of death worldwide over the past decades. Unstable angina is a clinical syndrome intermediate in severity between stable angina and acute myocardial infarction with high morbidity and mortality. Standard drug therapy and invasive revascularization are effective in decreasing progression to infarction, reducing symptoms and multiple hospitalizations, in most cases without a decrease in the long-term mortality rate. However, there are still many patients with persistence or recurrence of angina despite standard medical therapy and/or revascularization. Wen Xin granule, as a Chinese herbal medicine has shown great effect in patients with unstable angina in our clinical. However, there is still insufficient evidence on his specific efficacy and safety. Therefor, we'd like to evaluate the efficacy and safety of Wen Xin granule in patients with unstable angina through this multi-center, double-blind, randomized placebo-controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Wen Xin granule | one dose daily, two times per day. |
| DRUG | Clopidogrel Hydrogen Sulfate 75 MG Oral Tablet | one tablet daily. (for patients who can't use aspirin) |
| DRUG | Atorvastatin Calcium | 20 mg tablet, one tablet each night. |
| DRUG | Isosorbide Mononitrate Tab 20 MG | one tablet, twice daily. |
| DRUG | Metoprolol Tartrate Tab 25 MG | 12.5 mg or 25 mg, two times daily. |
| DRUG | Aspirin Enteric-coated Tablets | 100mg tablet, one tablet daily. |
| DRUG | WXG placebo | one dose daily, two times per day. |
| DRUG | Trimetazidine Dihydrochloride Tablets | 20 mg tablet, one tablet three times daily. |
| DRUG | glyceryl trinitrate | be taken when angina pectoris attacks. |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2023-03-01
- Completion
- 2023-06-01
- First posted
- 2020-12-10
- Last updated
- 2021-01-25
Source: ClinicalTrials.gov record NCT04661709. Inclusion in this directory is not an endorsement.